Gene Silencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product & Service (RNAi, CRISPR-Cas9, Antisense Oligonucleotides, Others), By Application (Neurology, Oncology, Infectious Diseases, Metabolic Diseases, Therapeutics Manufacturing, Others), By Region and Competition, 2020-2030F
North America RNA Therapeutics Market, By Product (Vaccines, Drugs), By Type (mRNA Therapeutics, RNA Interference (RNAi) Therapeutics, Antisense Oligonucleotide (ASO) Therapeutics, Other Therapeutics), By Indication (Infectious Diseases, Rare Genetic Diseases/Hereditary Diseases, Other Indications), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), By Country, Competition, Forecast and Opportunities, 2019-2029F
Biologics Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Monooclonal Antibodies, Vaccines, Recombinant Hormones/Proteins, Cell and Gene Therapy, and Others), Application (Cancer, Infectius Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), Manufacturing (Outsourced and In-house), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nucleic Acid Therapeutics Market (Product Type: RNA interference (RNAi) and Short Interfering RNAs, Antisense Oligonucleotides (ASOs), and Others; and Application: Autoimmune Disorders, Infectious Diseases, Genetic Disorders, Cancer, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
Global Antisense and RNAi therapeutics Market is valued approximately at USD 3.69 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 18.72% over the forecast period 2023-2030. Antisense and RNA interference (RNAi) therapeut…
Nucleic Acid Therapeutics CDMO Market Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029 Segmented By Type (Gene Therapy, RNA-based Therapies), By Service (Process Development & Optimization, Manufacturing Services, Analytical and Quality Control Services, others), by Application (Oncology, Genetic Disorders, Infectious Diseases, others), by region, and Competition
核酸治療薬CDMOの世界市場規模は2023年に109.6億米ドルとなり、2029年までのCAGRは9.10%で、予測期間中に目覚ましい成長が見込まれる。核酸治療薬CDMO(Contract Development and Manufacturing Organization)は、核酸ベースの治療薬の開発と製造のための専門知識とインフラ…
Antisense And RNAi Therapeutics Market Size, Share & Trends Analysis Report By Technology (RNA Interference, Antisense RNA), By Application (Ocular, Genetic), By Route of Administration (Intrathecal, Intravenous), By Region, And Segment Forecasts, 2024 - 2030
アンチセンスとRNAi治療薬市場の成長と動向
Grand View Research, Inc.の最新レポートによると、アンチセンスおよびRNAi治療薬の世界市場規模は、2024年から2030年にかけて18.72%のCAGRを記録し、2030年までに143億5000万米ドルに達すると予測されている。生物学的ベクター…